{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:07:17Z","timestamp":1769602037841,"version":"3.49.0"},"reference-count":32,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.3892\/ol.2014.2823","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T08:57:14Z","timestamp":1419325034000},"page":"1201-1206","source":"Crossref","is-referenced-by-count":19,"title":["Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy"],"prefix":"10.3892","volume":"9","author":[{"given":"RYOJI","family":"HASHIMOTO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MITSURO","family":"KANDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDEKI","family":"TAKAMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAI","family":"SHIMIZU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HISAHARU","family":"OYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SOKI","family":"HIBINO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUKIYASU","family":"OKAMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUGURU","family":"YAMADA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TSUTOMU","family":"FUJII","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GORO","family":"NAKAYAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROYUKI","family":"SUGIMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAHIKO","family":"KOIKE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUJI","family":"NOMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MICHITAKA","family":"FUJIWARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YASUHIRO","family":"KODERA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,12,23]]},"reference":[{"key":"key20180108102654_b1-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180108102654_b2-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3892\/ijo.2013.1829","article-title":"Human hepatocyte carcinogenesis (review)","volume":"42","author":"Shiraha","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180108102654_b3-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"key":"key20180108102654_b4-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1155\/2011\/310675","article-title":"Diagnostic and prognostic molecular markers in hepatocellular carcinoma","volume":"31","author":"M\u00ednguez","year":"2011","journal-title":"Dis Markers"},{"key":"key20180108102654_b5-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"key20180108102654_b6-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"SHARP Investigators Study Group: Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"issue":"5 Suppl 1","key":"key20180108102654_b7-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1053\/j.gastro.2004.09.013","article-title":"Hepatocellular carcinoma: recent trends in the United States","volume":"127","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"key20180108102654_b8-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1440-1746.2005.04043.x","article-title":"Review of genetic and epigenetic alterations in hepatocarcinogenesis","volume":"21","author":"Herath","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180108102654_b9-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jso.21095","article-title":"Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters","volume":"98","author":"Kanda","year":"2008","journal-title":"J Surg Oncol"},{"key":"key20180108102654_b10-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1349-7006.2012.02242.x","article-title":"Hepatocellular carcinoma: towards personalized medicine","volume":"103","author":"Miki","year":"2012","journal-title":"Cancer Sci"},{"key":"key20180108102654_b11-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2006-960171","article-title":"Genomics and signaling pathways in hepatocellular carcinoma","volume":"27","author":"Villanueva","year":"2007","journal-title":"Semin Liver Dis"},{"key":"key20180108102654_b12-ol-09-03-1201","first-page":"477","article-title":"Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis","volume":"35","author":"Kanda","year":"2009","journal-title":"Int J Oncol"},{"key":"key20180108102654_b13-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2010.10.021","article-title":"Melanoma-associated antigen genes-an update","volume":"302","author":"Sang","year":"2011","journal-title":"Cancer Lett"},{"key":"key20180108102654_b14-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1196\/annals.1322.040","article-title":"Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanisms","volume":"1028","author":"Chang","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"key20180108102654_b15-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/jnr.10160","article-title":"The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease","volume":"67","author":"Barker","year":"2002","journal-title":"J Neurosci Res"},{"key":"key20180108102654_b16-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3748\/wjg.v10.i13.1849","article-title":"Biological functions of melanoma-associated antigens","volume":"10","author":"Xiao","year":"2004","journal-title":"World J Gastroenterol"},{"key":"key20180108102654_b17-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000048822","article-title":"Expression pattern and further characterization of human MAGED2 and identification of rodent orthologues","volume":"94","author":"Langnaese","year":"2001","journal-title":"Cytogenet Cell Genet"},{"key":"key20180108102654_b18-ol-09-03-1201","article-title":"Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus","author":"Oya","year":"2013","journal-title":"Dis Esophagus"},{"key":"key20180108102654_b19-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jso.23440","article-title":"Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients","volume":"108","author":"Takami","year":"2013","journal-title":"J Surg Oncol"},{"key":"key20180108102654_b20-ol-09-03-1201","article-title":"International Union Against Cancer","volume-title":"TNM classification of malignant tumors","author":"Sobin","year":"2009","edition":"7th edition"},{"key":"key20180108102654_b21-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/mc.20735","article-title":"Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma","volume":"50","author":"Kanda","year":"2011","journal-title":"Mol Carcinog"},{"key":"key20180108102654_b22-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3449","article-title":"Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma","volume":"13","author":"Arzumanyan","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"key20180108102654_b23-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.3748\/wjg.v19.i33.5439","article-title":"Epigenetics of hepatocellular carcinoma: role of microRNA","volume":"19","author":"Khare","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key20180108102654_b24-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"Hernandez-Gea","year":"2013","journal-title":"Gastroenterology"},{"key":"key20180108102654_b25-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3892\/ijo.2013.2165","article-title":"Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma","volume":"44","author":"Kanda","year":"2014","journal-title":"Int J Oncol"},{"key":"key20180108102654_b26-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/dvdy.20026","article-title":"Comparative expression analysis of the MAGED genes during embryogenesis and brain development","volume":"230","author":"Bertrand","year":"2004","journal-title":"Dev Dyn"},{"key":"key20180108102654_b27-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbrc.2004.09.037","article-title":"Identification of a novel MAGE D2 antisense RNA transcript in human tissues","volume":"324","author":"Harper","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108102654_b28-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1245\/ASO.2006.12.011","article-title":"The role of genetic markers - NAP1L1, MAGE-D2, and MTA1 - in defining small-intestinal carcinoid neoplasia","volume":"13","author":"Kidd","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"key20180108102654_b29-ol-09-03-1201","first-page":"1205","article-title":"MAGED2: a novel p53-dissociator","volume":"31","author":"Papageorgio","year":"2007","journal-title":"Int J Oncol"},{"key":"key20180108102654_b30-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/cncr.21758","article-title":"Utility of molecular genetic signatures in the delineation of gastric neoplasia","volume":"106","author":"Kidd","year":"2006","journal-title":"Cancer"},{"key":"key20180108102654_b31-ol-09-03-1201","first-page":"305","article-title":"Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray","volume":"24","author":"Li","year":"2004","journal-title":"Int J Oncol"},{"key":"key20180108102654_b32-ol-09-03-1201","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/carcin\/bgs236","article-title":"The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells","volume":"33","author":"Tseng","year":"2012","journal-title":"Carcinogenesis"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2014.2823\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T13:18:54Z","timestamp":1515417534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2014.2823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,23]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,12,23]]},"published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.3892\/ol.2014.2823"],"URL":"https:\/\/doi.org\/10.3892\/ol.2014.2823","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,23]]}}}